Martin Escobar, age 57, of Youngstown, Ohio, was indicted by
a federal grand jury in a 145-count indictment charging the unlawful
distribution and dispensation of controlled substances, causing the deaths of
two patients, maintaining a drug-involved premises, health care fraud, and
unlawfully distributing and dispensing a controlled substance to a person under
the age of 21.
The indictment alleges that between March 2015 and May 2019,
Escobar prescribed opioids and other controlled substances out of his Lake
Milton medical office, including opioids such as oxycodone and hydrocodone,
often in combination with benzodiazepines and stimulants, all outside the usual
course of professional practice and not for a legitimate medical purpose.
The indictment further alleges that to support his illegal
prescribing, Escobar engaged in the following conduct, among other things: used
false diagnoses; falsified patient pain intensity scales in medical charts;
increased dosages of controlled substances and prescribed them for prolonged
periods without evidence of efficacy; failed to adequately investigate
patients’ pain complaints; failed to consider treatment options other than
controlled substances; and falsely claimed in patient charts to have performed
extensive physical examinations of patients.
The indictment also alleges that Escobar ignored the results of
patients’ urine drug screen tests, many of which were performed in Escobar’s
medical office and that Escobar billed the government for. The indictment further alleges that these
screens demonstrated the absence of prescribed controlled substances and the
presence of non-prescribed controlled substances, suggesting the patients were
abusing prescribed and non-prescribed controlled substances, and selling
prescribed controlled substances that Escobar prescribed to them on the illegal
secondary street market.
In addition, the indictment alleges that Escobar committed
health care fraud by billing and causing the government to be billed for
medically unnecessary controlled substances and urine drug screen tests.
The indictment further alleges that Escobar caused the
deaths of two of his patients in 2015 and 2016 by unlawfully distributing and
dispensing controlled substances to them that led to their deaths.
“We are relying on our community’s healthcare professionals
to help devise strategies to address the opioid crisis,” said U.S. Attorney
Justin Herdman. “The vast majority of doctors take their oath to do no harm
seriously and have embraced practices that lead to responsible prescribing and
reduce diversion, abuse, and addiction.
Where there may be departures from those professional obligations, as
alleged with respect to this defendant, we stand ready to use every law
enforcement tool, including criminal charges, to address that harm.”
“Today's indictment is another example of DEA's
determination to combat the troubling prescription drug abuse problem in this
country,” said Drug Enforcement Administration Detroit Field Division Special
Agent in Charge Keith Martin. “Dr.
Escobar allegedly abused his position of trust and jeopardized the lives of
many individuals by illegally prescribing controlled substances. No matter if
it’s in a doctor’s office, board room or street corner, DEA and our law
enforcement partners will continue to investigate and bring to justice those
who are responsible for the illegal distribution of prescription medicines.”
“All physicians are expected to uphold specific ethical
standards to do no harm, but Dr. Escobar, who took the Hippocratic oath to
become a physician, is accused of falsifying medical records, prescribing
unnecessary controlled substances subsequently causing two deaths, among other
charges,” stated FBI Special Agent in Charge Eric Smith. “Patients should be able to trust and rely
on their chosen physician, not become addicts or die as a result of their
physician's care. The FBI will continue
to work with our partners to root out and hold accountable physicians that are
violating the law and endangering their patients.”
“Prescribing controlled substances outside the usual course
of professional practice and with no legitimate medical purpose puts a
patient’s health and safety at risk,” said Lamont Pugh III, Special Agent in
Charge, U.S. Department of Health & Human Services, Office of Inspector
General – Chicago Region. “Prescribing patterns such as those alleged in this
indictment are serious in nature and only exacerbate the opioid crisis. The OIG
will continue to work with our law enforcement partners to vigorously
investigate allegations of this nature.”
“Every time a pill mill grinds to a halt, Ohio moves closer
to ending this crisis,” Ohio Attorney General Dave Yost said. “Ohio needs
Medicaid fraud teams like these to hold these operations accountable.”
An indictment is only a charge and is not evidence of guilt. A defendant is entitled to a fair trial in
which it will be the government’s burden to prove guilt beyond a reasonable
doubt.
If convicted, the defendant’s sentence will be determined by
the Court after review of factors unique to this case, including the
defendant’s prior criminal record, if any, the defendant’s role in the offense
and the characteristics of the violation.
In all cases, the sentence will not exceed the statutory maximum and in
most cases it will be less than the maximum.
The case was investigated by the Drug Enforcement
Administration, the Federal Bureau of Investigation, the Department of Health
and Human Services Office of Inspector General, the Medicaid Fraud Control Unit
of the Ohio Attorney General’s Office, and the Ohio Board of Pharmacy. It is being prosecuted by Assistant U.S.
Attorneys Brendan D. O’Shea, Michael L. Collyer, and Special Assistant U.S.
Attorney Jonathan L. Metzler of the Ohio Attorney General’s Office.
If you believe that you may have relevant information about
Martin Escobar, you are asked to contact law enforcement at (216) 583-5314.
Posts
No comments:
Post a Comment